Clinical trials have demonstrated substantial reductions in hemoglobin A1c levels (up to 2.4% reduction at the 15 mg dose) and significant weight loss (average of 15% of body weight at 10 mg and 20.9% at 15 mg in the SURMOUNT-1 obesity trial)
Future therapies in the GLP-1 pipeline include more effective new drugs like dual-action agonists, oral pill versions for weight loss, and combination therapies designed to preserve muscle mass during weight loss
When will generic semaglutide be available
It's intended for people who have obesity (a body mass index, or BMI, of 30 or higher) and those with overweight (a BMI of 27 or greater) with at least one weight-related condition, such as diabetes, hypertension, or high cholesterol
A diet that is high in protein, fiber, fruits, and vegetables can help people feel full longer and avoid overeating